Candidura, Candidemia and Candidal Endocarditis
1) Review Candiduria and Indications for treatment
- Candiduria is extremely common and usually represents colonization, not true infection.
- Main risk factor is presence of foley
- Do not treat asymptomatic candiduria, unless 1) Neutropenic, or 2) Undergoing urological procedure (e.g. TURP).
- However, if isolate candida from multiple sites (i.e. sputum and urine), in the appropriate clinical setting can be worrisome for disseminated candidiasis.
- For symptomatic candiduria, best treatment is to remove foley. If that doesn't work, Fluconazole is drug of choice. Ampho B bladder washes are NOT recommended (high relapse rate, and associated with higher mortality vs fluconazole). Echinocandins do not reliably penetrate the urine.
2) Candidemia: Significance of blood cultures, Clinical Presentation and Workup, and Risk Factors
- Blood cultures are insensitive for candidemia (as opposed to bacteremia - more sensitive). Classically, ~50% sensitive (but newer blood culture systems likely better than that).
- NEVER DISREGARD CANDIDA IN THE BLOOD AS A CONTAMINANT. Believe it or not, a few times a year this happens. ALWAYS TREAT CANDIDEMIA AND WORK IT UP: i.e., find out why he is candidemic, look for complications (i.e. endophthalmitis, possibly endocarditis)
- Clinical presentation can range from asymptomatic to septic shock - again, even if pt looks well, never disregard candida in the blood as contaminant!!
- All pts with candidemia automatically warrant an ophtho consult for a dilated retinal exam to r/o endophthalmitis, which occurs in ~10-25% of cases. Significance of this is that if severe eye lesions are present, this warrants combination therapy (i.e. Amphoterecin + Flucytosine) and much longer course of therapy (> 6 weeks minimum).
- Always dc and replace central lines in patients with candidemia
Risk Factors for Invasive Candidiasis - note that candida is part of the endogenous bowel flora, and also transmitted nosocomially on hands of health-care workers.
- Central lines - Candida is the 4th most common cause of CVC infections
- Broad spectrum antibiotics
- TPN - fungi love the nutritious medium (esp C.parapsilosis)
- Neutropenia, immunocompromised (often due to gut translocation)
- IV drug abuse
- Bowel surgery esp with anastomotic leaks
3) Review Antifungal Agents for Candidiasis.
- Fluconazole - can be used for C.albicans, C.parapsilosis, and C. tropicalis. C.glabrata and C.krusei are resistant and increasingly common. Excellent PO bioavailability.
- Echinocandins (Caspofungin, Micafungin, Anidulafungin) - work against virtually all strains, except potentially C.parapsilosis (higher MICs in vitro, but still usually responds clinically) --> drugs of choice for most pts (esp unstable pts) with candidemia
- Amphoterecin B - works against most (not all) strains of Candida, but little advantage over echinocandins and much more toxic
4) Management of Candidal Endocarditis:
- Medical: Per 2009 IDSA guidelines, warrants combination therapy with Amphoterecin B + Flucytosine, or Amphoterecin B + Echinocandin.
- Surgical: Strong indication for valve replacement therapy, as very difficult to eradicate with antifungals alone.
** Other indications for surgery in endocarditis:
Class I: - New onset heart failure due to valvular dysfunction, or hemodynamic deterioration
- Invasive complications: Perivalvular abscess, conduction abnormalities
- Fungal endocarditis, or other highly resistant organisms
Class II:- Large (> 10 mm) vegetations
- Recurrent systemic emboli while on appropriate antimicrobial therapy.
(Chanu Rhee MD, 7/23/10)